2.31%C 7.40 5.37%QQQQ 27.81 2.83%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
ITHACA, N.Y. - Biotechnology company Vybion Inc. said Wednesday it will sell its recombinant protein business to Meridian Biosciences Inc., which makes and markets diagnostic test kits primarily for respiratory, gastrointestinal, viral, and parasitic infectious diseases.
| VIVO | 22.66 |  -0.67 |
Financial details were not disclosed. Both companies expect the deal to close in the next 60 days.
Privately held Vybion, which is based in Ithaca, N.Y., is also eligible to receive royalty payments from Meridian on sales of related products.
Vybion Chief Executive Officer Lee Henderson said divesting the business will allow it to focus efforts on its preclinical drug candidate for cocaine abuse, CoMab.
Shares of Cincinnati-based Meridian fell 19 cents to $28.85 in afternoon trading.
U.S. stocks were mixed on Thursday after retailers reported mostly disappointing sales while other big-name companies announced layoffs and Europ...
Toyota Tsusho Corp (8015.TSE), a trading house affiliated to the Toyota Motor Corp., is set to import rare-earth metals from India and Vietnam, a...
The markets have spoken: risk aversion is still the name of the game and that was obvious since the beginning of the week.
Get your next web design project done with our los angeles web design team - Best web design with great price.
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Building your business and corporate credit for your small business.
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
